Results 141 to 150 of about 11,996 (225)

Safety of Vancomycin Use Through Midline Catheters for Outpatient Parenteral Antimicrobial Therapy.

JAMA Intern Med
Paje D, Walzl E, Heath M, McLaughlin E, Horowitz JK, Tatarcuk C, Swaminathan L, Kaatz S, Malani AN, Gupta A, Vaughn VM, Bernstein SJ, Flanders SA, Chopra V.   +13 more
europepmc   +1 more source

Propensity Score-Weighted Analysis of the Impact of Outpatient Parenteral Antimicrobial Therapy Plan Reconciliation on Unscheduled Care. [PDF]

Open Forum Infect Dis
Ross JK, Sieling WD, Billmeyer KN, Hirsch EB, Evans MD, Kline SE, Galdys AL.   +6 more
europepmc   +1 more source

2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer [PDF]

, 2017
Armstrong, Donald, Bodey, Gerald P., Bow, Eric J., Brown, Arthur E., Calandra, Thierry, Feld, Ronald, Hughes, Walter T., Pizzo, Philip A., Rolston, Kenneth V. I., Shenep, Jerry L., Young, Lowell S.   +10 more
core  

Are Oritavancin and Dalbavancin More Cost Effective for Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Medical Center? [PDF]

Fed Pract
Hanks D, Jodlowski TZ, Madaras-Kelly K, Diaz J, Vietri N.   +4 more
europepmc   +1 more source

Clinical Outcomes of Piperacillin/Tazobactam Treatment in Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs: Comparison of Two Models of Opat Care. [PDF]

Pharmaceutics
Lora-Escobar SJ, Herrera-Hidalgo L, Castillo-Fernández N, Palacios-Baena ZR, Luque-Márquez R, De Alarcón A, Guisado-Gil AB, Gutierrez-Gutierrez B, Navarro-Amuedo MD, Praena-Segovia J, Mejías Trueba M, Carmona-Caballero JM, Sánchez Oliva JM, Gil-Navarro MV, López-Cortés LE.   +14 more
europepmc   +1 more source

Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey. [PDF]

JAC Antimicrob Resist
Wolie ZT, Roberts JA, López-Cortés LE, Mirón-Rubio M, Pollard J, Marizan Nor AN, Abdul-Aziz MH, Jamieson C, Seaton RA, Gilchrist M, Sime FB.   +10 more
europepmc   +1 more source

Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy. [PDF]

Antimicrob Steward Healthc Epidemiol
Wiley MB, Bennett KK, Siegrist EA, Neely SB, Sassine J, White BP.   +5 more
europepmc   +1 more source

Challenges in monitoring vancomycin in outpatient parenteral antimicrobial therapy: opportunities for mitigation utilizing OSHA's framework for mitigating workplace hazards. [PDF]

Antimicrob Steward Healthc Epidemiol
Regli DC, Warner S, Wilcox E, Zimmerman J, Bittner MJ.   +4 more
europepmc   +1 more source